NKECHI ONYEGASI: Open Payments
NPI 1932538501 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 28 payments from 8 companies in 2025. Trend: 2023 $294 · 2024 $374 · 2025 $1,376
Consulting: $861Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $947 |
| Corcept Therapeutics | 4 | $165 |
| ABBVIE INC. | 10 | $137 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Rhythm Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Korlym, QULIPTA, SPRAVATO, Wegovy, UBRELVY, Cologuard Collection Kit, PAXLOVID, IMCIVREE.
Industry payments across TX — which companies pay providers there.
